
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated July 19, 2021, titled "Balaxi Pharmaceuticals further diversifies geographical mix, reports 23% YoY increase in Profit After Tax for Q1FY22".
Filed with NSE ·

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated July 19, 2021, titled "Balaxi Pharmaceuticals further diversifies geographical mix, reports 23% YoY increase in Profit After Tax for Q1FY22".
6ix hasn’t read this filing yet.
Balaxi Pharmaceuticals Limited on 6ix
Follow Balaxi Pharmaceuticals into a list and get an email when it puts out news.
Follow Balaxi Pharmaceuticals